This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Niemeyer, M.G. Articles by Niemeyer, M. G. Search for Related Content PubMed PubMed Citation Articles by Niemeyer, M.G. Articles by Niemeyer, M. G. Social Bookmarking                         What's this?

Comparison of Thallium Scintigraphy and Positron Emission Tomography

A.F.M. Kuijper

J.G. Meeder, MD

M.J.M. Cramer, MD

A.J.M. Cleophas, MD

E.E. van der Wall, MD

Menco G. Niemeyer, MD

Department of Radiology Division of Nuclear Medicine Leiden University Medical Center Building 1, C5-Q Rijnsburgerweg 10 2333 AA Leiden, The Netherlands

Assessment of tissue viability has become an important issue in recent years. Scintigraphic measurements have provided important diagnostic, therapeutic, and prognostic infor mation in patients with myocardial dysfunction, who may improve in left ventricular function after revascularization. For detection of regional myocardial ischemia and viability, thallium 201 (²⁰¹T1) has been the most widely used tracer in single-photon scintigraphy. However, ²⁰¹T1 scintigraphy may underestimate regional viability, espe cially after myocardial infarction. Positron emission tomography (PET) provides an advanced imaging technology that permits the accurate definition of regional tracer distribution. In combination with nitrogen (¹³N) ammonia, PET allows for the sensitive and specific detection of coronary artery disease. Several studies indicate the superiority of this approach in comparison with standard ²⁰¹T1 tomographic (SPECT) imaging. In addition, regional blood flow can be accurately measured with ¹³N ammonia PET, and this approach can be employed in conjunction with pharmacologic stress imaging to quantify regional flow reserve. In combination with metabolic markers, such as fluorine 18 (¹⁸F) deoxyglucose, an indicator of glucose uptake, PET is capable of assessing myocardial viability. Furthermore, the PET approach may differentiate between various forms of cardiomyopathy. More studies are needed to define the cost-benefit ratio of both the ²⁰¹ T1 reinjection and the PET technique for the management of patients with coronary artery disease or cardiomyopathy.

Angiology, Vol. 48, No. 10, 843-853 (1997)
DOI: 10.1177/000331979704801001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?